- Home
- Publications
- Publication Search
- Publication Details
Title
CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC)
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 7, Issue 10, Pages 303
Publisher
MDPI AG
Online
2018-09-25
DOI
10.3390/jcm7100303
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PD-1/PD-L1 Axis in Lung Cancer
- (2018) Fernando C. Santini et al. CANCER JOURNAL
- Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3
- (2018) Philip M. Murphy et al. CYTOKINE
- Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies
- (2018) Amnon Peled et al. CYTOKINE
- The chemical diversity and structure-based evolution of non-peptide CXCR4 antagonists with diverse therapeutic potential
- (2018) Dian Peng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study
- (2018) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- The eighth edition TNM stage classification for lung cancer: What does it mean on main street?
- (2018) Frank C. Detterbeck JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Higher Lung Cancer Incidence in Young Women Than Young Men in the United States
- (2018) Ahmedin Jemal et al. NEW ENGLAND JOURNAL OF MEDICINE
- A New Standard of Care for Advanced Lung Cancer
- (2018) Joan H. Schiller NEW ENGLAND JOURNAL OF MEDICINE
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
- (2018) Matthew D. Hellmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Emerging biomarkers for immune checkpoint inhibition in lung cancer
- (2018) George Cyriac et al. SEMINARS IN CANCER BIOLOGY
- Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment
- (2018) Florian Lüke et al. Oncotarget
- AMD3100 Augments the Efficacy of Mesothelin-Targeted, Immune-Activating VIC-008 in Mesothelioma by Modulating Intratumoral Immunosuppression
- (2018) Binghao Li et al. Cancer Immunology Research
- An update on small molecules targeting CXCR4 as starting points for the development of anti-cancer therapeutics
- (2017) Fedora Grande et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- CXCR4 Ligands: The Next Big Hit?
- (2017) Annemiek M.E. Walenkamp et al. JOURNAL OF NUCLEAR MEDICINE
- A randomized phase II study of LY2510924 and carboplatin/etoposide versus carboplatin/etoposide in extensive‐disease small cell lung cancer
- (2017) Ravi Salgia et al. LUNG CANCER
- Targeting CXCR4-dependent immunosuppressive Ly6Clowmonocytes improves antiangiogenic therapy in colorectal cancer
- (2017) Keehoon Jung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET
- (2017) Ido D. Weiss et al. Oncotarget
- Distinct mobilization of leukocytes and hematopoietic stem cells by CXCR4 peptide antagonist LY2510924 and monoclonal antibody LY2624587
- (2017) Sheng-Bin Peng et al. Oncotarget
- CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma
- (2017) Constantin Lapa et al. Theranostics
- A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC)
- (2016) John D. Hainsworth et al. Targeted Oncology
- Expression of the CXCR4 ligand SDF-1/CXCL12 is prognostically important for adenocarcinoma and large cell carcinoma of the lung
- (2016) William Sterlacci et al. VIRCHOWS ARCHIV
- [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer - initial experience
- (2016) Constantin Lapa et al. Oncotarget
- Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment
- (2015) S. Scala CLINICAL CANCER RESEARCH
- CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
- (2015) Yunching Chen et al. HEPATOLOGY
- The 2015 World Health Organization Classification of Lung Tumors
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway
- (2015) Meng-Feng Tsai et al. Scientific Reports
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood
- (2011) R. Franco et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification
- (2011) W. D. Travis et al. EUROPEAN RESPIRATORY JOURNAL
- Potential of CXCR4 antagonists for the treatment of metastatic lung cancer
- (2011) Jan A Burger et al. Expert Review of Anticancer Therapy
- Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: Role in non–small cell lung cancer tumor proliferation
- (2011) Ori Wald et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- CXCR4 Overexpression Is Associated with Poor Outcome in Females Diagnosed with Stage IV Non-small Cell Lung Cancer
- (2011) Shannon Otsuka et al. Journal of Thoracic Oncology
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer
- (2011) Yao-Ling Lee et al. LUNG CANCER
- CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
- (2010) Xueqing Sun et al. CANCER AND METASTASIS REVIEWS
- High-Level CXCR4 Expression Correlates with Brain-Specific Metastasis of Non-Small Cell Lung Cancer
- (2010) Gang Chen et al. WORLD JOURNAL OF SURGERY
- The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation
- (2009) M Abraham et al. LEUKEMIA
- CXCL12 and CXCR4 in adenocarcinoma of the lung: Association with metastasis and survival
- (2008) Patrick L. Wagner et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now